Drugs for Pulmonary Mycoses

Hay RJ . Antifungal therapy and the new azole compounds. J Antimicrob Chemother 1991;28(Suppl A):35–46.

Lyman CA , Walsh TJ . Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 1992;44(1):9–35.

Graybill JR . Future directions of antifungal chemotherapy. Clin Infect Dis 1992;14(Suppl 1):S170–S181.

Bodey GP . Azole antifungal agents. Clin Infect Dis 1992;14 (Suppl 1):S161–S169.

Terrell CL , Hughes CE . Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc 1992;67(1):69–91.

Como JA , Dismukes WE . Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330 (4):263–272.

Gallis HA , Drew RH , Picard WW . Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12(2):308–329.

Schmitt H-J . New methods of delivery of amphotericin B. Clin Infect Dis 1993;17(Suppl 2):S501–S506.

Francis P , Walsh TJ . Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 1992;15(6):1003–1018.

Joly V , Bolard J , Yeni P. In vitro models for studying toxicity of antifungal agents. Antimicrob Agents Chemother 1992;36(9):1799–1804.

Loose DS , Kan PB , Hirst MA , Marcus RA , Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest 1983;71(5):1495–1499.

Pont A , Graybill JR , Craven PC , Galgiani JN , Dismukes WE , Reitz RE , Stevens DA . High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 1984;144(11):2150–2153.

Galgiani JN . Fluconazole, a new antifungal agent. Ann Intern Med 1990;113(3):177–179.

Grant SM , Clissold SP . Fluconazole: a review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39(6):877–916.

Grant SM , Clissold SP . Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37(3):310–344.

Sharkey PK , Rinaldi MG , Dunn JF , Hardin TC , Fetchick RJ , Graybill JR . High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother 1991;35(4):707–713.

Dismukes WE , Bradsher RW Jr , Cloud GC , Kauffman CA , Chapman SW , George RB , . Itraconazole therapy for blastomycosis and histoplasmosis: NIAID Mycoses Study Group. Am J Med 1992;93(5):489–497.

Saag MS , Dismukes WE . Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 1988;32(1):1–8.

Van Cutsem J , Van Gerven F , Janssen PAJ . Oral and parenteral therapy with saperconazole (R66905) of invasive aspergillosis in normal and immunocompromised animals. Antimicrob Agents Chemother 1989;33(12):2063–2068.

Franco L , Gomez I , Restropo A. Treatment of subcutaneous and disseminated mycoses with saperconazole (abstract PS 3.99). In: Proceedings of the 11th Congress of the International Society of Human and Animal Mycology. Leeds UK: International Society for Human and Animal Mycology, 1991.

Kobayashi GS , Spitzer ED . Testing of organisms for susceptibility to triazoles: is it justified? Eur J Clin Microbiol Infect Dis 1989;8(5):387–389.

Galgiani JN . Susceptibility testing of fungi: current status of the standardization process. Antimicrob Agents Chemother 1993;37(12):2517–2521.

Mehta RT , McQueen TJ , Keyhani A , Lopez-Berestein G. Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. J Infect Dis 1991;164(5):1003–1006.

Barrett JF , Klaubert DH . Recent advances in antifungal agents. Ann Rep Med Chem 1992;27:149–158.

Hostetler JS , Hanson LH , Stevens DA . Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob Agents Chemother 1992;36(2):477–480.

Liu S , Oguntimein B , Hufford CD , Clark AM . 3-Methoxysampangine, a novel antifungal copyrine alkaloid from Cleistopholis patens. Antimicrob Agents Chemother 1990;34(4):529–533.

Oki T , Tenmyo O , Hirano M , Tomatsu K , Kamei H. Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. J Antibiot Tokyo 1990;43(7):763–770.

Walsh TJ , Lee JW . Prevention of invasive fungal infections in patients with neoplastic disease. Clin Infect Dis 1993;17(Suppl 2):S468–S480.

Conneally E , Cafferkey MT , Daly PA , Keane CT , McCann SR . Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 1990;5(6):403–406.